Investigation of the effects of Theranekron and Sorafenib treatments on carcinogenesis, apoptosis and biochemical profile in hepatocellular carcinoma in rats

References

• Akcakavak G, Ozdemır O. 2023. Effect of Tarantula cubensis alcoholic extract on tumour pathways in azoxymethane-induced colorectal cancer in rats. Acta Vet Brno. 92(1):79–88. doi: 10.2754/avb202392010079.
   Web of Science ®Google Scholar
• Akcakavak G, Celik Z, Karatas O, Dogan O, Ozdemir O, Tuzcu M. 2024. Tarantula cubensis alcohol extract enhances the tumoricidal effect of capecitabine via multiple pathways in azoxymethane-induced colorectal cancer in rats. Trop J Pharm Res. 23(2):291–297. doi: 10.4314/tjpr.v23i2.8.
   Google Scholar
• Akdağ A, Yenisey Ç, Epikmen TE, Ateş E. 2023. Effect of intravesical tarantula cubensis extract (Theranekron) on inflammation in an interstitial cystitis rat model. LUTS. 15(2):63–67. doi: 10.1111/luts.12470.
   Google Scholar
• Aksit D, Aksit H, Altun E, Celebi C, Celebi M. 2023. Investigation of the protective effect of Tarantula cubensis extract on the liver and brain of rats exposed to gentamicin. Acta Vet Brno. 92(2):205–211. doi: 10.2754/avb202392020205.
   Web of Science ®Google Scholar
• Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. 2020. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 1873(1):188314. doi: 10.1016/j.bbcan.2019.188314.
   PubMed Web of Science ®Google Scholar
• Arboatti AS, Lambertucci F, Sedlmeier MG, Pisani G, Monti J, Álvarez MdL, Francés DEA, Ronco MT, Carnovale CE. 2018. Diethylnitrosamine increases proliferation in early stages of hepatic carcinogenesis in insulin-treated type 1 diabetic mice. Biomed Res Int. 2018: 939. doi: 10.1155/2018/9472939.
   Web of Science ®Google Scholar
• Bhatia N, Gupta P, Singh B, Koul A. 2015. Lycopene enriched tomato extract inhibits hypoxia, angiogenesis, and metastatic markers in early stage N-nitrosodiethylamine induced hepatocellular carcinoma. Nutr Cancer. 67(8):1268–1275. doi: 10.1080/01635581.2015.1087040.
   PubMed Web of Science ®Google Scholar
• Boice A, Bouchier-Hayes L. 2020. Targeting apoptotic caspases in cancer. Biochim Biophys Acta Mol Cell Res. 1867(6):118688. doi: 10.1016/j.bbamcr.2020.118688.
   PubMed Web of Science ®Google Scholar
• Canbar R, Ozdemir O, Levent Bas A. 2023. Effect of Tarantula cubensis alcohol extract and Capecitabin combine in Colorectal Cancer rats. RC Fcv-Luz. XXXIII(2):1–8. doi: 10.52973/rcfcv-e33254.
   Google Scholar
• Cao M, Xu Y, Youn J-i, Cabrera R, Zhang X, Gabrilovich D, Nelson DR, Liu C. 2011. Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Lab Invest. 91(4):598–608. doi: 10.1038/labinvest.2010.205.
   PubMed Web of Science ®Google Scholar
• Carr BI, Akkiz H, Bag HG, Karaoğullarından U, Yalçın K, Ekin N, Özakyol A, Altıntaş E, Balaban HY, Şimşek H, et al. 2021. Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis. J Transl Sci. 7(3):. doi: 10.15761/jts.1000446.
   Google Scholar
• Cervello M, Bachvarov D, Lampiasi N, Cusimano A, Azzolina A, McCubrey JA, Montalto G. 2012. Molecular mechanisms of sorafenib action in liver cancer cells. Cell Cycle. 11(15):2843–2855. doi: 10.4161/cc.21193.
   PubMed Web of Science ®Google Scholar
• Chung YM, Khan PP, Wang H, Tsai W-B, Qiao Y, Yu B, Larrick JW, Hu MC-T. 2021. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3. J Immunother Cancer. 9(12):e002772. doi: 10.1136/jitc-2021-002772.
   PubMed Web of Science ®Google Scholar
• Deniz GY, Laloglu E, Koc K, Geyikoglu F. 2019. Hepatoprotective potential of Ferula communis extract for carbon tetrachloride induced hepatotoxicity and oxidative damage in rats. Biotech Histochem. 94(5):334–340. doi: 10.1080/10520295.2019.1566831.
   PubMed Web of Science ®Google Scholar
• Desoky A, Zyan K. 2021. Newcastle and Doxorubicin attenuated against diethylnitrosoamine as antitumor effects which induced hepatocellular carcinoma. Benha Veterinary Med J. 40(1):94–98. doi: 10.21608/bvmj.2021.61407.1337.
   Google Scholar
• Dik B, Coskun D, Er A. 2022. Protective effect of Nerium oleander Distillate and Tarantula cubensis alcoholic extract on cancer biomarkers in colon and liver tissues of rats with experimental colon cancer. Anticancer Agents Med Chem. 22(10):1962–1969. doi: 10.2174/1871520621666210903120253.
   PubMed Web of Science ®Google Scholar
• Ding W, Hu W, Wang X, Dong X. 2010. Expressions of Survivin and Caspase-3 in human hepatocellular carcinoma and the relationship with prognosis. Chin -Ger J Clin Oncol. 9(11):628–632. doi: 10.1007/s10330-010-0689-z.
   Google Scholar
• Ding Y-F, Wu Z-H, Wei Y-J, Shu L, Peng Y-R. 2017. Hepatic infammation-fbrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine. J Cancer Res Clin Oncol. 143(5):821–834. doi: 10.1007/s00432-017-2364-z.
   PubMed Web of Science ®Google Scholar
• Elmetwalli A, Diab T, Albalawi AN, El-Naggar SA, El-Far AH, Ghedan AR, Alamri ES, Salama AF. 2023. Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action. Naunyn Schmiedebergs Arch Pharmacol. 396(10):2501–2517. doi: 10.1007/s00210-023-02470-0.
   PubMed Web of Science ®Google Scholar
• Erzurumlu Y, Dogan HK, Catakli D, Aydogdu E. 2022. Tarantula cubensis extract induces cell death in prostate cancer by promoting autophagic flux/ER stress responses and decreased epithelial-mesenchymal transition. Rev Bras Farmacogn. 32(4):575–582. doi: 10.1007/s43450-022-00279-1.
   Google Scholar
• Fathy A, Eldin MM, Metwally L. 2009. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma. Egyptian J Immunol. 16(2):17–25.
   PubMedGoogle Scholar
• Flecken T, Schmidt N, Hild S, Gostick E, Drognitz O, Zeiser R, Schemmer P, Bruns H, Eiermann T, Price DA, et al. 2014. Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma. Hepatology. 59(4):1415–1426. doi: 10.1002/hep.26731.
   PubMed Web of Science ®Google Scholar
• Fujikawa K, Shiraki K, Sugimoto K, et al. 2000. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma. Anticancer Res. 20(3B):1927–1932.
   PubMed Web of Science ®Google Scholar
• Ghasemi-Dizgah A, Nami B, Amirmozafari N. 2017. Tarantula cubensis venom (Theranekron®) selectively destroys human cancer cells via activating caspase-3-mediated apoptosis. Acta Med Int. 4(1):74. doi: 10.5530/ami.2017.4.14.
   Google Scholar
• Gültiken N, Vural MR. 2007. The effect of Tarantula cubensis extract applied in pre and postoperative period of canine mammary tumours. J Istanbul Vet Sci. 2:13–23.
   Google Scholar
• Goping IS, Barry M, Liston P, Sawchuk T, Constantinescu G, Michalak KM, Shostak I, Roberts DL, Hunter AM, Korneluk R, et al. 2003. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity. 18(3):355–365. doi: 10.1016/s1074-7613(03)00032-3.
   PubMed Web of Science ®Google Scholar
• Hage C, Hoves S, Strauss L, Bissinger S, Prinz Y, Pöschinger T, Kiessling F, Ries CH. 2019. Sorafenib induces pyroptosis in macrophages and triggers natural killer cell–mediated cytotoxicity against hepatocellular carcinoma. Hepatology. 70(4):1280–1297. doi: 10.1002/hep.30666.
   PubMed Web of Science ®Google Scholar
• Hatipoğlu D, Keskin E. 2022. The effect of curcumin on some cytokines, antioxidants and liver function tests in rats induced by Aflatoxin B1. Heliyon. 8(7):e09890. doi: 10.1016/j.heliyon.2022.e09890.
   PubMed Web of Science ®Google Scholar
• Hay ZL, Slansky JE. 2022. Granzymes: the molecular executors of immune-mediated cytotoxicity. Int J Mol Sci. 23(3):1833. doi: 10.3390/ijms23031833.
   PubMed Web of Science ®Google Scholar
• Hong G, Xie S, Guo Z, Zhang D, Ge S, Zhang S, Gao W. 2022. Progression-free survival of a patient with advanced hepatocellular Carcinoma treated with adoptive cell therapy using natural killer cells: a case report. Onco Targets Ther. 15:255–266. doi: 10.2147/OTT.S344707.
   PubMed Web of Science ®Google Scholar
• Hu J, Wang E, Liu L, Wang Q, Xia D, Bai W, Tie J, Li X, Yuan J, Yang S, et al. 2020. Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells. Invest New Drugs. 38(5):1247–1256. doi: 10.1007/s10637-019-00885-2.
   PubMed Web of Science ®Google Scholar
• Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. 2007. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 26(15):2166–2176. doi: 10.1038/sj.onc.1210279.
   PubMed Web of Science ®Google Scholar
• İlhan S. 2021. Can a veterinary drug be repurposed for human cancers? Cytotoxic effect of tarantula cubensis venom on human cancer cells. JIST. 11(3):1763–1769. doi: 10.21597/jist.864028.
   Google Scholar
• Jing L, Ruan Z, Sun H, Li Q, Han L, Huang L, Yu S, Wang Y, Guo H, Jiao M, et al. 2019. Epithelial–mesenchymal transition induced cancer‐stem‐cell‐like characteristics in hepatocellular carcinoma. J Cell Physiol. 234(10):18448–18458. doi: 10.1002/jcp.28480.
   PubMed Web of Science ®Google Scholar
• Kalathil SG, Hutson A, Barbi J, Iyer R, Thanavala Y. 2019. Augmentation of IFN-γ+ CD8+ T cell responses correlates with survival of HCC patients on sorafenib therapy. JCI Insight. 4(15):e130116. doi: 10.1172/jci.insight.130116.
   PubMed Web of Science ®Google Scholar
• Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S. 2021. Abnormal liver enzymes: a review for clinicians. World J Hepatol. 13(11):1688–1698. doi: 10.4254/wjh.v13.i11.1688.
   PubMed Web of Science ®Google Scholar
• Karabacak M, Eraslan G, Kanbur M, Sarıca ZS. 2015. Effects of Tarantula cubensis D6 on aflatoxin-induced injury in biochemical parameters in rats. Homeopathy. 104(3):205–210. doi: 10.1016/j.homp.2015.02.005.
   PubMed Web of Science ®Google Scholar
• Keskin E, Hatipoğlu D. 2018. Granzimlerin Apoptotik ve Non-Apoptotik Etkileri. Kocatepe Vet J. 11(1):96–103.
   Google Scholar
• Kischkel FC, Lawrence DA, Tinel A, et al. 2001. Death receptor recruitment of endogenous caspase-10 and Apoptosis initiation in the absence of Caspase-8*. J Biol Chem. 49:46639–46646.
   Google Scholar
• Kurma K, Zeybek Kuyucu A, Roth GS, Sturm N, Mercey-Ressejac M, Abbadessa G, Yu Y, Lerat H, Marche PN, Decaens T, et al. 2022. Effect of Novel AKT inhibitor vevorisertib as single agent and in combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. Int J Mol Sci. 23(24):16206. doi: 10.3390/ijms232416206.
   PubMed Web of Science ®Google Scholar
• Larimer BM, Wehrenberg-Klee E, Dubois F, Mehta A, Kalomeris T, Flaherty K, Boland G, Mahmood U. 2017. Granzyme B PET imaging as a predictive biomarker of immunotherapy response. Cancer Res. 77(9):2318–2327. doi: 10.1158/0008-5472.
   PubMed Web of Science ®Google Scholar
• Lin H, Wong GL-H, Zhang X, Yip TC-F, Liu K, Tse YK, Hui VW-K, Lai JC-T, Chan HL-Y, Wong VW-S, et al. 2022. U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases. Clin Mol Hepatol. 28(1):77–90. doi: 10.3350/cmh.2021.0188.
   PubMed Web of Science ®Google Scholar
• Ma H, Zhang L, Tang B, Wang Y, Chen R, Zhang B, Chen Y, Ge N, Wang Y, Gan Y, et al. 2014. γ-Glutamyltranspeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma. Ann Surg Oncol. 21(9):3084–3089. doi: 10.1245/s10434-014-3724-4.
   PubMed Web of Science ®Google Scholar
• Mei Z, Gao X, Pan C, Wu Q, Wang S, Qian J, Xu Z, Xu K, Zhou L, Zhen S, et al. 2023. Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1+ CD8+ T cells in HCC via blocking VEGFR2. Cancer Sci. 114(4):1284–1296. doi: 10.1111/cas.15719.
   PubMed Web of Science ®Google Scholar
• Mohamed FE, Al-Jehani RM, Minogue SS, Andreola F, Winstanley A, Olde Damink SWM, Habtesion A, Malagó M, Davies N, Luong TV, et al. 2015. Effect of toll‐like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. Liver Int. 35(3):1063–1076. doi: 10.1111/liv.12626.
   PubMed Web of Science ®Google Scholar
• Ozdemir O, Akcakavak G, Tuzcu M. 2022. Effect of Tarantula cubensis alcoholic extract and Nerium oleander distillate on cell proliferation markers in colon carcinogenesis. RC Fcv-Luz. XXXII(single):1–8. doi: 10.52973/rcfcv-e32150.
   Google Scholar
• Persad R, Liu C, Wu T-T, Houlihan PS, Hamilton SR, Diehl AM, Rashid A. 2004. Overexpression of caspase-3 in hepatocellular carcinomas. Mod Pathol. 17(7):861–867. doi: 10.1038/modpathol.3800146.
   PubMed Web of Science ®Google Scholar
• Ram AK, Vairappan B, Srinivas B. 2020. Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis. World J Gastroenterol. 26(45):7131–7152. doi: 10.3748/wjg.v26.i45.7131.
   PubMed Web of Science ®Google Scholar
• Sahoo G, Samal D, Khandayataray P, Murthy MK. 2023. A review on caspases: key regulators of biological activities and apoptosis. Mol Neurobiol. 60(10):5805–5837. doi: 10.1007/s12035-023-03433-5.
   PubMed Web of Science ®Google Scholar
• Savran M, Ascı H, Erzurumlu Y, Ozmen O, Ilhan I, Sırın MC, Karakuyu NF, Karaibrahimoglu A. 2022. Theranekron: a Novel anti-inflammatory candidate for acetic acid-induced colonic inflammation in rats. Mol Biol Rep. 49(9):8753–8760. doi: 10.1007/s11033-022-07722-5.
   PubMed Web of Science ®Google Scholar
• Sieghart W, Pinter M, Dauser B, Rohr-Udilova N, Piguet A-C, Prager G, Hayden H, Dienes H-P, Dufour J-F, Peck-Radosavljevic M. 2012. Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. J Hepatol. 57(3):592–599. doi: 10.1016/j.jhep.2012.04.034.
   PubMed Web of Science ®Google Scholar
• Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. 2002. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. Embo J. 21(17):4520–4530. doi: 10.1093/emboj/cdf441.
   PubMed Web of Science ®Google Scholar
• Sprinzl MF, Reisinger F, Puschnik A, Ringelhan M, Ackermann K, Hartmann D, Schiemann M, Weinmann A, Galle PR, Schuchmann M, et al. 2013. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells. Hepatology. 57(6):2358–2368. doi: 10.1002/hep.26328.
   PubMed Web of Science ®Google Scholar
• Sun B, Zhang J, Wang B. 2000. Expression of caspase3 gene does not correlate with tumor cell apoptosis in primary hepatocellular carcinoma. Zhonghua Zhong liu za zhi. 22(1):39–41.
   PubMedGoogle Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Tanyeli A, Eraslan E, Guler M, Sebin S, Celebi D, Ozgeris F, Toktay E. 2019. Investigation of biochemical and histopathological effects of tarantula cubensis D6 on lung tissue in cecal ligation and puncture-induced polymicrobial sepsis model in rats. Int J Med Sci. 8(3):644–650. doi: 10.5455/medscience.2019.08.9045.
   Google Scholar
• Tatipamula VB, Thonangi CV, Dakal TC, Vedula GS, Dhabhai B, Polimati H, Akula A, Nguyen HT. 2022. Potential anti-hepatocellular carcinoma properties and mechanisms of action of clerodane diterpenes isolated from Polyalthia longifolia seeds. Sci Rep. 12(1):9267. doi: 10.1038/s41598-022-13383-y.
   PubMed Web of Science ®Google Scholar
• Tosun NG, Kaplan Ö, Özgür A. 2021. Apoptosis induced by Tarantula cubensis crude venom (Theranekron® D6) in cancer cells. Rev Bras Farmacogn. 31(6):824–831. doi: 10.1007/s43450-021-00221-x.
   Google Scholar
• Wang K, Wang X, Zhang M, Ying Z, Zhu Z, Tam KY, Li C, Zhou G, Gao F, Zeng M, et al. 2023. Trichosanthin promotes anti-tumor immunity through mediating chemokines and Granzyme B secretion in hepatocellular carcinoma. Int J Mol Sci. 24(2):1416. doi: 10.3390/ijms24021416.
   PubMed Web of Science ®Google Scholar
• Wang S, Chen L, Liu W. 2022. Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma. Cancer Cell Int. 22(1):318. doi: 10.1186/s12935-022-02634-7.
   PubMed Web of Science ®Google Scholar
• Yao X, Zhao C-R, Yin H, Wang K, Gao J-J. 2020. Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells. Acta Pharmacol Sin. 41(12):1609–1620. doi: 10.1038/s41401-020-0395-5.
   PubMed Web of Science ®Google Scholar
• Yi C, Chen L, Lin Z, Liu L, Shao W, Zhang R, Lin J, Zhang J, Zhu W, Jia H, et al. 2021. Lenvatinib targets FGF receptor 4 to enhance antitumor immune response of anti–programmed cell death‐1 in HCC. Hepatology. 74(5):2544–2560. doi: 10.1002/hep.31921.
   PubMed Web of Science ®Google Scholar
• Yoshiji H, Noguchi R, Namisaki T, Moriya K, Kitade M, Aihara Y, Douhara A, Kawaratani H, Nishimura N, Fukui H, et al. 2014. Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis. J Gastroenterol. 49(10):1421–1429. doi: 10.1007/s00535-013-0906-y.
   PubMed Web of Science ®Google Scholar
• Yoshino H, Futakuchi M, Cho Y-M, Ogawa K, Takeshita F, Imai N, Tamano S, Shirai T. 2005. Modification of an in vivo lung metastasis model of hepatocellular carcinoma by low dose N-nitrosomorpholine and diethylnitrosamine. Clin Exp Metastasis. 22(5):441–447. doi: 10.1007/s10585-005-2807-9.
   PubMed Web of Science ®Google Scholar
• Youssef MM, Tolba MF, Badawy NN, Liu AW, El-Ahwany E, Khalifa AE, Zada S, Abdel-Naim AB. 2016. Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells. Sci Rep. 6(1):30717. doi: 10.1038/srep30717.
   PubMedGoogle Scholar
• Zhang W, Song Z, Xiao J, Liu X, Luo Y, Yang Z, Luo R, Li A. 2019. Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated cytokine-induced killer cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma. J Cancer. 10(11):2578–2587. doi: 10.7150/jca.26961.
   PubMed Web of Science ®Google Scholar